Results 231 to 240 of about 91,813 (306)

Fetal development and growth of the human neck axial musculature. [PDF]

Anat Cell Biol
Suzuki S, Miyamoto E, Yoshihashi Y, Yamamoto M, Murakami G, Abe SI, Rodríguez-Vázquez JF.   +6 more
europepmc   +1 more source

The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteristics

Cancer Cytopathology, Volume 134, Issue 5, May 2026.
Abstract The nucleus of papillary thyroid carcinoma (PTC) has had a fascinating history since its early descriptions by Lindsay in 1960 and his designation of follicular variant papillary thyroid carcinoma (FVPTC) as a subtype of follicular carcinoma (FC). Later, Chen and Rosai revived the awareness of FVPTC and aligned this neoplasm with PTC.
N. Paul Ohori, Jeremy M. Minkowitz, Yuri E. Nikiforov, Raja R. Seethala   +3 more
wiley   +1 more source

Subaxial sagittal shifts postatlantoaxial fusion - Radiological assessment and clinical analysis. [PDF]

J Craniovertebr Junction Spine
Singh DK, Sangolli PN, Singh N, Mishra VK, Vashisth KK.   +4 more
europepmc   +1 more source

Computational Design of an mRNA Vaccine Targeting LRP6 for Triple‐Negative Breast Cancer Therapy

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Triple‐negative breast cancer (TNBC) presents a poorer prognosis than other breast cancer subtypes, attributed to its aggressive nature and the lack of specific therapeutic interventions. TNBC has high recurrence rates and limited survival despite current therapies, emphasizing the critical need for improved treatment options.
Pooriya Teimoori, Mohammadreza Heidari
wiley   +1 more source

Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Ubiquitin‐specific protease 22, an important catalytic component of the human SAGA (Spt‐Ada‐GcN5 Acetyltransferase) complex, regulates the deubiquitination and methylation of histones, which in turn influences gene expression. Its overexpression alters gene regulation, transcription, cancer progression, and therapy resistance.
Uma Devi A., Prakash Kumar Shukla
wiley   +1 more source

KIF20A promotes cervical cancer progression by interacting with CLIP1. [PDF]

Sci Rep
Ma X, Xu Z, Chen Y, Jiang F, Jiao Y, Wang W, Wang E.   +6 more
europepmc   +1 more source

From DNA Methylation Microarray to Digital PCR: A Stepwise Strategy for Tissue Specific cfDNA Biomarker Development

Journal of Clinical Laboratory Analysis, Volume 40, Issue 9, May 2026.
Overview of a DNA methylation biomarker development pipeline, from discovery and assay design to screening, performance evaluation, and specificity testing in clinical sample matrices. ABSTRACT Background Tissue‐specific cell‐free DNA (cfDNA) offers promise as a minimally invasive biomarker of organ injury.
David H. Murray, Nicky Boulter, Shanon Ranjit, Natasha M. Rogers, Sarah Kummerfeld, Jason P. Ross, Rodney J. Scott   +6 more
wiley   +1 more source

The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer. [PDF]

Clinics (Sao Paulo)
Wang B, Zhu Y, Ru Z, Zhang Y, Yu M, Li P, Zhang M, Ding J, Chen Z.   +8 more
europepmc   +1 more source

Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma

Molecular Carcinogenesis, Volume 65, Issue 5, Page 603-614, May 2026.
ABSTRACT Functional DNA methylation abnormalities are a hallmark of human cancers and may be a promising biomarker for their early diagnosis. Moreover, the largest methylation differences can improve the sensitivity of noninvasive diagnoses of solid tumors.
Junsheng Zhao, Sijia Shen, Junjie Zhang, Ying Xu, Jing Peng, Hainv Gao, Lanjuan Li   +6 more
wiley   +1 more source